Legacy Capital Group California »

Biogen Idec shares owned by Legacy Capital Group California

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Legacy Capital Group California from 13F filings

Historical chart of Legacy Capital Group California investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Legacy Capital Group California consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Legacy Capital Group California

Quarter filed Position value Share count Share price at filing
2023-12-31 $253k 976 258.77
2023-09-30 $223k 866 257.01
2023-06-30 $215k 754 284.85

More positions owned by Legacy Capital Group California

Apple (AAPL)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Microsoft Corporation (MSFT)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Spdr Ser Tr Bloomberg Invt (FLRN)
First Tr Exchng Traded Fd Vi Cboe Vest Us Eqt (FAPR)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Ser Tr Portfoli S&p1500 (SPTM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Fs Kkr Capital Corp (FSK)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Merck & Co (MRK)

View all positions for Legacy Capital Group California

Top funds holding Biogen Idec

PRIMECAP Management Company
Vanguard Group
Wellington Management Company
Jpmorgan Chase & Co
ClearBridge Advisors
Legal & General Group
T. Rowe Price Associates
Norges Bank Investment Management
Dimensional Fund Advisors
Van Eck Associates Corp.
Bank of New York Mellon
Amundi
Deutsche Bank Aktiengesellschaft
Goldman Sachs Group
Ubs Global Asset Management Americas

View all funds holding Biogen Idec